Opioid
Dependence
Deterrence
Welcome to a solution for mitigating opioid addiction before it starts.
Imagine a world where judicious prescribing and additive pharmacology curtail the rate of new cases of opioid dependency—from the source.
This tool should galvanize healthcare providers and practitioners in prescribing practice protection.
The opioid epidemic is not a problem for law enforcement alone. It’s a public health issue,
a medical issue, and it’s a moral issue.
— Barack Obama
PATENT CLAIMS
Problem: Physical dependence and rapid tolerance have always been an issue with opioids—whether extracted from the opium poppy (Papaver somniferum), developed in the lab, or formulated to be extended release or abuse-resistant. Further, when licit or semi-licit channels for servicing dependence close, illicit and often more deleterious modes are pursued.
Solution: Recognizing that opioids shine for acute pain but unleash a multi-layer cascade of issues when used for any extended period, this patent enables the enhancement of opioid therapy in the short-term while minimizing dosing requirements. By implementing a multi-pathway approach to pain and inflammation management, it establishes a prescriber bulwark against opioid over-use.
More Depth
The opioid crisis rages on even if it is less in the news. This far-reaching U.S. patent creates a patient-specific prescribing system designed to mitigate the worst ills of the crisis by eliminating unintentional prescriber initiation. By utilizing a smart-dosing algorithm that incorporates cannabinoids and other non-addictive substances to combinatorily address pain and tamp-down inflammation, this technology helps to increase patient safety, decrease runaway dose-escalation which often leads to addiction, and protect prescribers by managing prescribing compliance.
Value
KEY
Prescriber Control
By monitoring the intangibles, the prescribing engine allows health practitioners focus on what is best for patients.
Smarter Medicine
Why use a lot of substance A, if a little of B and a little of C works just as well. Pharmacology can operate in more than one-dimension.
Better Outcomes
Combinatorial pharmacological approaches, when done right, can maximize efficacy AND maximize safety.
Stronger Compliance
Tracking prescriber activity and patient renewal activity turns doctors into cops, hospital administrators into jailers, patients into criminals and insurers into wardens. A prescribing engine tool and tracker cuts through weak links and wires a more robust fence.
Who Should License
U.S. Patent 12,020,794 makes beginning of the pipe opioid amelioration possible. The following entities should see that value in that:
-
Litigation for cases of opioid abuse continue to be brought to the doorsteps of the originating prescriber. Use this tool to optimize health outcomes, avoid prescriber error and backstop operational responsibility.
-
Add prescription check and AI-supported recommendations to compliance platforms. The utility of better outcomes and decreased dependence risk will drive physician acceptance beyond approaches that offer simple compliance with HIPAA, HITECH and the 21st Century Act.
-
To stop the problems before they start, opioid advocacy groups recognize blame cannot continue to be lobbed at patients. Smarter therapeutic management needs to be the focus.